​

Insmed (INSM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INSM Stock Forecast

Insmed (INSM) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $76.25, with a high of $95.00 and a low of $54.00. This represents a 4.35% increase from the last price of $73.07.

$20 $35 $50 $65 $80 $95 High: $95 Avg: $76.25 Low: $54 Last Closed Price: $73.07

INSM Stock Rating

Insmed stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (92.86%), 0 Hold (0.00%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 0 13 Strong Sell Sell Hold Buy Strong Buy

INSM Price Target Upside V Benchmarks

TypeNameUpside
StockInsmed4.35%
SectorHealthcare Stocks 23.50%

Price Target Trends

1M3M12M
# Anlaysts--20
Avg Price Target--$68.30
Last Closing Price$73.07$73.07$73.07
Upside/Downside---6.53%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 25612---18
Feb, 25512---17
Jan, 25612---18
Dec, 24612---18
Nov, 246121--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 15, 2024Graig SuvannavejhMizuho Securities$92.00$73.4325.29%25.91%
Aug 09, 2024Tiago FauthWells Fargo$85.00$71.8118.37%16.33%
Jul 09, 2024Vamil DivanGuggenheim$95.00$70.0535.62%30.01%
Jul 01, 2024Nicole GerminoTruist Financial$88.00$67.0031.34%20.43%
Jun 25, 2024Leon WangBarclays$90.00$69.7129.11%23.17%
Jun 21, 2024Liisa BaykoEvercore ISI$75.00$66.1913.31%2.64%
Jun 07, 2024Graig SuvannavejhMizuho Securities$82.00$57.1743.43%12.22%
Jun 05, 2024Stephen WilleyStifel Nicolaus$74.00$57.0029.82%1.27%
May 29, 2024Tiago FauthWells Fargo$77.00$53.5543.79%5.38%
May 29, 2024Andrew FeinH.C. Wainwright$70.00$48.0645.65%-4.20%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 06, 2025UBSBuyBuyhold
Aug 09, 2024Cowen & Co.BuyBuyhold
Aug 09, 2024Wells FargoOverweightOverweighthold
Jul 12, 2024Morgan StanleyOverweightOverweighthold
Jul 09, 2024GuggenheimBuyBuyhold
Jul 05, 2024Cowen & Co.BuyBuyhold
Jul 02, 2024H.C. WainwrightBuyBuyhold
Jun 25, 2024BarclaysOverweightOverweighthold
Jun 21, 2024Evercore ISIOutperformOutperformhold
May 29, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.01$-3.88$-3.91$-5.34$-5.57----
Avg Forecast$-2.60$-3.82$-3.72$-5.21$-5.36$-4.35$-2.65$0.86$4.09
High Forecast$-2.22$-3.26$-3.04$-5.10$-5.21$-3.10$-0.94$4.06$5.65
Low Forecast$-3.02$-4.43$-4.82$-5.34$-5.57$-5.38$-4.65$-0.81$3.23
Surprise %15.77%1.57%5.11%2.50%3.92%----

Revenue Forecast

$0 $800M $2B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$164.41M$188.46M$245.36M$305.21M$363.71M----
Avg Forecast$164.47M$179.85M$247.85M$303.42M$357.89M$506.74M$1.03B$1.94B$2.87B
High Forecast$184.87M$202.16M$304.60M$392.20M$364.25M$660.57M$1.04B$2.51B$3.71B
Low Forecast$145.97M$159.62M$213.35M$303.41M$351.53M$414.94M$1.02B$1.63B$2.40B
Surprise %-0.03%4.79%-1.00%0.59%1.62%----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-294.09M$-434.65M$-481.53M$-749.57M$-913.77M----
Avg Forecast$-250.25M$-400.47M$-434.01M$-749.57M$-757.05M$-595.36M$-478.57M$157.64M$574.37M
High Forecast$-200.20M$-320.37M$-347.20M$-599.65M$-732.14M$-435.02M$-131.70M$570.16M$792.86M
Low Forecast$-300.30M$-480.56M$-520.81M$-899.48M$-781.97M$-755.70M$-652.68M$-113.75M$453.50M
Surprise %17.52%8.54%10.95%-20.70%----

INSM Forecast FAQ

Is Insmed stock a buy?

Insmed stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Insmed is a favorable investment for most analysts.

What is Insmed's price target?

Insmed's price target, set by 14 Wall Street analysts, averages $76.25 over the next 12 months. The price target range spans from $54 at the low end to $95 at the high end, suggesting a potential 4.35% change from the previous closing price of $73.07.

How does Insmed stock forecast compare to its benchmarks?

Insmed's stock forecast shows a 4.35% upside, underperforming the average forecast for the healthcare stocks sector (23.50%).

What is the breakdown of analyst ratings for Insmed over the past three months?

  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 29.41% Strong Buy, 70.59% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Insmed’s EPS forecast?

Insmed's average annual EPS forecast for its fiscal year ending in December 2025 is $-4.35, marking a -21.90% decrease from the reported $-5.57 in 2024. Estimates for the following years are $-2.65 in 2026, $0.86 in 2027, and $4.09 in 2028.

What is Insmed’s revenue forecast?

Insmed's average annual revenue forecast for its fiscal year ending in December 2025 is $506.74M, reflecting a 39.33% increase from the reported $363.71M in 2024. The forecast for 2026 is $1.03B, followed by $1.94B for 2027, and $2.87B for 2028.

What is Insmed’s net income forecast?

Insmed's net income forecast for the fiscal year ending in December 2025 stands at $-595M, representing a -34.85% decrease from the reported $-914M in 2024. Projections indicate $-479M in 2026, $157.64M in 2027, and $574.37M in 2028.